U.S. Markets open in 6 hrs 15 mins

Here's Why Novo Nordisk A/S Gained 12% in August

newsfeedback@fool.com (Cory Renauer)
Here's Why Novo Nordisk A/S Gained 12% in August

Last summer, the diabetes-focused pharmaceutical issued distressing guidance due to pricing pressure worries, but the forecast troubles failed to arrive.